Normal physiology undergoes 24-hour changes in function, that include
daily rhythms in circulating/hormones, most notably melatonin and cortical
steroids. This study focuses on N-acetyltryptamine, a little-studied melatonin
receptor mixed agonist/antagonist and the likely evolutionary precursor of
melatonin. The central issue addressed was whether N-acetyltryptamine is
physiologically present in the circulation. N-Acetyltrypamine was detected by
LC-MS/MS in daytime plasma of three different mammals in subnanomolar levels
(mean ± SEM: rat, 0.29 ± 0.05 nM, N=5; rhesus macaque, 0.54
± 0.24 nM, N=4; human, 0.03 ± 0.01 nM, N=32). Twenty four hour
blood collections from rhesus macaques revealed a nocturnal increase in plasma
N-acetyltryptamine (P < 0.001), which varied from 2- to 15- fold over
daytime levels among the four animals studied. Related RNA sequencing studies
indicated that the transcript encoding the tryptamine acetylating enzyme
arylalkylamine N-acetyltransferase (AANAT) is expressed at similar levels in the
rhesus pineal gland and retina, thereby indicating that either tissue could
contribute to circulating N-acetyltryptamine. The evidence that
N-acetyltryptamine is a physiological component of mammalian blood and exhibits
a daily rhythm, together with known effects as a melatonin receptor ligand
shifts the status of N-acetyltryptamine from pharmacological tool to that of a
candidate for a physiological role. This provides a new opportunity to extend
our understanding of 24-hour biology.